25 Mar CoJourney
Lijun Wang, Ph.D., CEO
April 29 | 2:15pm | Salone dei Cavalieri, Section 1
Hangzhou, China/Horsham, PA
(Private)
CoJourney is a global CDMO specializing in end-to-end plasmid DNA and AAV manufacturing for preclinical through clinical programs, with a strong technical presence in both the U.S. and China. The company is known for its innovative Zero-Chrom® plasmid platform, a column-chromatography–free process that significantly reduces production cost, accelerates timelines, and minimizes cross-contamination risks. CoJourney also offers high-titer, high–full-capsid AAV manufacturing, leveraging optimized suspension processes and deep CMC expertise to deliver consistent quality and superior yields. Beyond manufacturing, CoJourney supports clients navigating China’s Investigator-Initiated Trial (IIT) pathway, enabling faster access to first-in-human data through its established relationships with leading hospitals and regulatory experts. With more than two decades of combined leadership experience in gene therapy CMC, CoJourney provides technical guidance, regulatory insight, and flexible partnership models to help innovators move from research to clinic quickly, reliably, and cost-effectively.